Australian pharma Phebra sets up UK operations
Australian pharma Phebra has set up operations in the UK with the establishment of a new wholly-owned subsidiary company.
Read More
Tag: injectables
- Tremfya data show sustained remission in ulcerative colitis through 3 years
- Brensocatib becomes first licensed treatment for non‑cystic fibrosis bronchiectasis
- Lario Therapeutics awarded $2.4m to advance calcium channel platform
- Mikrobiomik secures approval for gut‑microbiota therapy for C difficile infection
- Exdensur approved in EU for severe asthma and CRSwNP
